Neko Health
Total Raised
$331.25MInvestors Count
9Deal Terms
3Funding, Valuation & Revenue
6 Fundings
Neko Health has raised $331.25M over 6 rounds.
Neko Health's latest funding round was a Series B for $260M on January 22, 2025.
Neko Health's valuation in July 2023 was $101.1M.
Neko Health's latest post-money valuation is from January 2025.
Sign up for a free demo to see Neko Health's valuations in January 2025, March 2021 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/22/2025 | Series B | $260M | Lightspeed Venture Partners, Atomico, General Catalyst, Lakestar, O.G. Venture Partners, and Rosello | 8 | ||
7/5/2023 | Series A | $101.1M | ||||
1/4/2022 | Unattributed - III | |||||
3/16/2021 | Unattributed - II | |||||
4/18/2019 | Unattributed |
Date | 1/22/2025 | 7/5/2023 | 1/4/2022 | 3/16/2021 | 4/18/2019 |
|---|---|---|---|---|---|
Round | Series B | Series A | Unattributed - III | Unattributed - II | Unattributed |
Amount | $260M | ||||
Investors | Lightspeed Venture Partners, Atomico, General Catalyst, Lakestar, O.G. Venture Partners, and Rosello | ||||
Valuation | $101.1M | ||||
Revenue | |||||
Sources | 8 |
Neko Health Deal Terms
3 Deal Terms
Neko Health's deal structure is available for 3 funding rounds, including their Series B from January 22, 2025.
Round | Series B | Series A | Unattributed - II |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A | |||||||||||||||
Unattributed - II |
Neko Health Investors
9 Investors
Neko Health has 9 investors. General Catalyst invested in Neko Health's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/5/2023 | 1/22/2025 | 2 Series A, Series B (2025) | Venture Capital | California | ||
Venture Capital | United Kingdom | |||||
Venture Capital | Switzerland | |||||
Holding Company | Cyprus | |||||
Venture Capital | California |
First funding | 7/5/2023 | ||||
|---|---|---|---|---|---|
Last Funding | 1/22/2025 | ||||
Investor | |||||
Rounds | 2 Series A, Series B (2025) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Holding Company | Venture Capital |
Location | California | United Kingdom | Switzerland | Cyprus | California |
Compare Neko Health to Competitors
Kitman Labs is a performance intelligence company that operates in the sports and defense sectors. The company offers a suite of software solutions designed to optimize human performance, enhance health and wellness, reduce injury risk, and improve operational efficiencies. Kitman Labs primarily serves professional sports leagues, governing bodies, collegiate sports programs, and defense organizations. It was founded in 2012 and is based in Dublin, Ireland.
Humanity is a health technology company that monitors and analyzes aging biomarkers. The company offers a subscription service that utilizes AI algorithms to track and predict aging processes based on digital and blood biomarkers, and provides insights for users to make lifestyle changes related to aging. Humanity primarily serves the health and wellness industry, with a focus on individuals seeking to improve their health. It was founded in 2019 and is based in Boston, Massachusetts.
Prenuvo provides whole-body Magnetic resonance imaging (MRI) scans for preventative health care, operating within the medical imaging and diagnostic services industry. The company offers health assessments that utilize MRI technology to detect conditions early, without the use of radiation or contrast dyes. Prenuvo's services cater to individuals seeking health monitoring and detection of potential health issues. It was founded in 2018 and is based in Redwood City, California.
Smarter Diagnostics provides AI-powered diagnostics within the healthcare sector, focusing on sports medicine and preventive healthcare. The company offers imaging diagnostic services that analyze MRI data to assist in athletic performance, injury prevention, and health monitoring for athletes and active individuals. Smarter Diagnostics serves professional sports, healthcare providers, employers, and insurance companies. It was founded in 2020 and is based in Warsaw, Poland.
Loading...